Drug prescribing for children in general practice. A report from the More & Romsdal Prescription Study

被引:42
作者
Straand, J [1 ]
Rokstad, K [1 ]
Heggedal, U [1 ]
机构
[1] Univ Bergen, Div Gen Practice, Dept Publ Hlth & Primary Care, N-5009 Bergen, Norway
关键词
D O I
10.1080/08035259850157705
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To investigate general practitioners' drug prescribing patterns for children (0-12 y), an observational, cross-sectional study was conducted in Western Norway. Seven thousand, two hundred and twenty-nine GP-patient contacts during which 5222 drugs were prescribed, were included for analysis. The highest prescribing rates were for boys < 2 y (82.1 prescriptions per 100 contacts). Two-thirds of ail prescriptions were for drugs in main groups respiratory system or systemic anti-infectives. The 20 most commonly prescribed agents comprised 75% of all prescriptions, The 20 most frequently recorded diagnoses for prescribing comprised 81% of all. Phenoxymethylpenicillin was the most frequently prescribed antibiotic for otitis, tonsillitis and sinusitis, while erythromycin was used most often for bronchitis and pneumonia. Antibiotics were prescribed in more than 8/10 contacts for tonsillitis, sinusitis, acute bronchitis and pneumonia, and in two-thirds of all contacts for urinary tract infections. Sixty-five percent of the antibiotic prescriptions for urinary tract infections were for co-trimoxazole.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 30 条
[1]  
ANDREW M, 1990, Tidsskrift for den Norske Laegeforening, V110, P3215
[2]  
Andrew Marit, 1994, Tidsskrift for den Norske Laegeforening, V114, P169
[3]  
Arason VA, 1996, BMJ-BRIT MED J, V313, P387
[4]  
ARNOFF SC, 1996, AM FAM PHYSICIAN, V54, P46
[5]  
Aronoff SC, 1996, AM FAM PHYSICIAN, V54, P44
[6]  
ARONOFF SC, 1996, AM FAM PHYSICIAN, V54, P56
[7]  
ARONOFF SC, 1996, AM FAM PHYSICIAN, V54, P54
[8]  
ARONOFF SC, 1996, AM FAM PHYSICIAN, V54, P46
[9]  
Berlin CM, 1996, PEDIATRICS, V98, P143
[10]   EPIDEMIOLOGIC EVALUATION OF DRUG-USE IN CHILDREN [J].
BONATI, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (04) :300-305